BMSN Stock | Investment in Stock | Should I buy? | Stock Research

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Bio-Matrix Scientific Group, Inc. BMSN Company Overview 

Stock Message Board http://investorshangout.com/search?q=BMSN&...mp;yt1=Go!

Last Updated: Saturday, October 12, 2013 12:09:57 PM

Bio-Matrix Scientific Group, Inc. BMSN Current Price and Quotes
Last Price 0.0022
Previous Close 0.0026 Open 0.0026
Daily Range 0.0027 - 0.0019 52wk Range 0.0165 - 0.0002
Volume 29,366,067 Dividend N/A
Average Vol (3m) 30,373,279 Yield N/A
Bio-Matrix Scientific Group, Inc. BMSN
Company Information

4700 Spring Street
Suite 304
La Mesa, CA 91942

Website: http://www.bmsn.us
Phone: 619-702-1404
Email: info@bmsn.us

Bio-Matrix Scientific Group, Inc. BMSN
Bio-Matrix Scientific Group Inc. is a biotechnology research and development company headquartered in San Diego, Ca. with a 15,000 sq. ft. facility that houses two secure cryogenic stem cell banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing lab, hematology, microbiology and flow cytometry laboratories.

Bio-Matrix is pursuing relationships with hospitals, medical institutes, research firms and biotechnology companies to assist in stem cell researc...



Bio-Matrix Scientific Group, Inc. BMSN
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001079282
Fiscal Year End 9/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 7389 - Business services, misc
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

David R. Koos CEO, President
Company Directors

David R. Koos Chairman
Company Notes

Formerly=Tasco Holdings International, Inc. until 9-06
Formerly=Tasco International, Inc. until 8-05
Service Providers

Auditor/Accountant
Seale and Beers, CPAs, LLC
50 S. Jones Blvd.
2nd Floor
Las Vegas, NV, 89107
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Bio-Matrix Scientific Group, Inc. BMSN
BMSN Security Details

Share Structure

Market Value1 $4,385,258 a/o Oct 11, 2013
Shares Outstanding 1,993,299,049 a/o Aug 06, 2013
Float Not Available
Authorized Shares 80,000,000 a/o Jan 11, 2010
Par Value  0.0001
Shareholders

Shareholders of Record 451 a/o Mar 06, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) *  May 05, 2009 May 15, 2009
Dividend () *  May 28, 2008 Jun 10, 2008
Security Notes

Capital Change=shs increased by 10 for 1 split. Ex-date=08/29/2005.
Short Selling Data

Short Interest 44,149 (-81.54%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Securities Transfer Corp

Bio-Matrix Scientific Group, Inc. BMSN Recent News

Oct 9, 2013 Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen BioPharma Dividend to Be Paid to Shareholders
Sept 26, 2013 Bio-Matrix Scientific Group's Subsidiary Regen BioPharma Enters Into Preclinical Trials Agreement for HemaXellerate I Covering Aplastic Anemia
Sept 25, 2013 Bio-Matrix Scientific Group's Subsidiary, Regen BioPharma Announces dCellVax Breast Cancer Immunotherapeutic Product
Sept 17, 2013 Bio-Matrix Scientific Group Recruits RNA Interference Pioneer Dr. David Suhy to Regen BioPharma Inc.'s Scientific Advisor Board
Aug 16, 2013 Bio-Matrix Scientific Group Discusses Regen BioPharma's Cancer Immunotherapy Program
Aug 8, 2013 Regen BioPharma Inc. Licenses Cancer Gene Silencing Technology From Benitec BioPharma
Jul 31, 2013 Bio-Matrix Scientific Group Provides Update on Its Regen BioPharma's HemaXellerate I(TM) Clinical Program


Bio-Matrix Scientific Group, Inc. BMSN Financials
Period Ending Sep 30, 2012 Sep 30, 2011 Sep 30, 2010 Sep 30, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 18 51 417 129
Sales, General and Admin. 778 843 1,251 1,878
Non-Recurring Items - - - -
Other - - - -
Operating Income (795) (894) (1,667) (2,007)
Income From Continuing Operations

Add'l Income/Expense Items (129) 41,282 - (458)
Earnings Before Interest and Tax (924) 40,387 (1,667) (2,465)
Interest Expense 429 63 91 117
Earnings Before Tax (1,354) 40,324 (1,759) (2,582)
Income Tax - - - -
Minority Interest - (230) (213) (94)
Equity Earnings Unconsolidated Subsidiary (399) (265) - -
Net Income Cont. Operations (1,794) 40,290 (1,546) (2,488)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,794) 40,290 (1,546) (2,488)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,753) 40,290 (1,546) (2,488)

BMSN Bio-Matrix Scientific Group, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BMSN&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BMSN/quote
Stock Chart http://www.otcmarkets.com/stock/BMSN/chart
Company Info http://www.otcmarkets.com/stock/BMSN/company-info
Recent News http://www.otcmarkets.com/stock/BMSN/news
Financials http://www.otcmarkets.com/stock/BMSN/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BMSN/filings
Short Sales http://www.otcmarkets.com/stock/BMSN/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BMSN/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BMSN/research
Summary http://finance.yahoo.com/q?s=BMSN
Historical Prices http://finance.yahoo.com/q/hp?s=BMSN+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BMSN
Basic Chart http://finance.yahoo.com/q/bc?s=BMSN+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BMSN+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BMSN+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BMSN+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BMSN+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BMSN+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BMSN+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BMSN+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BMSN+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BMSN+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BMSN
Balance Sheet http://finance.yahoo.com/q/bs?s=BMSN
Cash Flow http://finance.yahoo.com/q/cf?s=BMSN+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BMSN
Market Watch http://www.marketwatch.com/investing/stock/BMSN
Bloomberg http://www.bloomberg.com/quote/BMSN:US
Morningstar http://quotes.morningstar.com/stock/s?t=BMSN
Bussinessweek http://investing.businessweek.com/research/st...icker=BMSN
Barchart http://www.barchart.com/quotes/stocks/BMSN
OTC Short Report http://otcshortreport.com/index.php?index=BMSN
Investopedia http://www.investopedia.com/markets/stocks/BMSN/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Danaher and Microsoft Put AI Into the Lab Stack Early

Updated Category News Views 26

Laboratory AI gets interesting only when it reaches the hardware bench, and Danaher is taking a serious swing at that ugly, complicated job with Microsoft. The Nov. 20 partnership is not just another chatbot bolted onto a dashboard. It is aimed at building a common agentic platform that can help instruments interpret scientific intent, guide setup, control hardware within...

Continue Reading
Candel’s BLA Delay Puts Disclosure Timing Under Fire

Updated Category News Views 163

A December filing turned into a mid-2027 wait, and Candel shareholders absorbed the damage in one ugly trading session. On November 13, shares of Candel Therapeutics fell 26% after the company disclosed that its biologics license application, or BLA, for aglatimagene in prostate cancer was no longer expected in December 2026. The revised plan is to submit in the middle of...

Continue Reading
Yangtze Documentary Frames a Decade of Economic Change

Updated Category News Views 85

A fish, a kilowatt-hour, a microchip, and a shipping container walk into the same economic story—well, not literally, thank goodness—and that is the unusual wager behind CCTV4’s upcoming Our Home, Our Yangtze. Announced in Beijing on November 19, 2026, the four-part documentary aims to recount a decade of change across the Yangtze River Economic Belt without leaning...

Continue Reading
Minnesota Giving Record Signals a Stressed Safety Net

Updated Category News Views 52

Thirty-eight million dollars landing in one day is no small civic heartbeat. Minnesota’s Give to the Max Day brought in a record $38.4 million in 2026 for nearly 6,000 nonprofits and schools, edging past the $37.8 million raised in 2025. More than 65,000 people gave. That deserves a clear-eyed nod, not a cynical shrug. Still, the number carries two messages at once. It...

Continue Reading
BET's HBCU Basketball Bet Is Bigger Than Six Games

Updated Category News Views 46

December television usually hands the microphone to the same old basketball machinery, which makes BET putting HBCU hoops in primetime feel overdue rather than merely promotional. Beginning December 3 at 8:00 p.m. ET, BET and Straight Shooter Media will air a six-game series built around Howard University and a rotating slate of opponents. The opener is Grambling State...

Continue Reading
Bella Rio's Proposed Preferred B Share Giveaway Plan

Updated Category News Views 46

A founder handing over two million of his own common shares is the sort of detail that makes investors stop stirring their coffee. Bella Rio Consulting, the company behind ROCK'N Vodka and Bella Rio Bourbon, says co-founder and Vice President Andy Roiniotis proposes to contribute 2,000,000 personally held Common shares for reclassification into Preferred Series B shares....

Continue Reading
BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 96

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
NEWWAVE Turns 15 and Chases a Bigger Tech Partner Role

Updated Category News Views 97

Fifteen years is about when an outsourced engineering shop has to prove it can be more than extra hands on a keyboard. NEWWAVE’s new identity and “Trusted Technology Partner” positioning are an attempt to make that jump: from carrying out software work to helping clients decide what work ought to be done, then sticking around after launch. It is a sensible ambition,...

Continue Reading
Arizona's Dry Climate Puts Scalp Health Under Stress

Updated Category News Views 16

Desert weather is unforgiving, and apparently the scalp does not get a pass. In a Nov. 20, 2026 discussion, Scottsdale and Tucson hair-restoration physician Dr. Sharon A. Keene frames Arizona hair concerns around something easy to overlook: the condition of the skin beneath the hair. That is a more sensible starting point than treating every strand in the shower like it...

Continue Reading
Early Home Care Signals Families Should Not Ignore

Updated Category News Views 5

A pill organizer sitting untouched can say more than a family conversation ever will. Jay Mann of Amada Senior Care in Richmond points to a hard truth in HelloNation's Nov. 20, 2026 article: the need for in-home support often arrives quietly, disguised as little breaks in routines that everybody would rather wave away. This is not a matter for armchair diagnosis, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Dynamics of the Automated Sortation System Market

Updated Category News Views 95

The Growth of the Automated Sortation System Market The automated sortation systems market is on a rapid ascent, projected to rise significantly and reach an estimated USD 5.68 billion by 2032. This thriving market, valued at approximately USD 4.00 billion in the previous year, demonstrates a vigorous compound annual growth rate (CAGR) of 3.99% from 2024 to 2032. The...

Continue Reading
Advancing Biopharmaceutical Manufacturing with New Ontologies

Updated Category News Views 148

Introducing Advanced Biopharmaceutical Manufacturing Ontologies In a groundbreaking development for the biopharmaceutical industry, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and Open Applications Group, Inc. (OAGi) have unveiled a set of innovative ontologies aimed at improving data interoperability and analytics. This...

Continue Reading
Illinois Tool Works Prepares for Third Quarter Earnings Call

Updated Category News Views 46

Illinois Tool Works Announces Earnings Webcast Schedule Illinois Tool Works Inc. (NYSE: ITW), a prominent name in global manufacturing, is set to release its third quarter results. The company will issue the results on a Wednesday morning at 7:00 a.m. CDT. Following this important announcement, ITW will host a webcast to discuss the outcomes and insights from their...

Continue Reading
Parry Labs Collaborates with Marines on Advanced Data Solutions

Updated Category News Views 158

Parry Labs Collaborates with Marines on Advanced Data Solutions Parry Labs, a leading defense technology firm known for its innovative hardware and digital infrastructure, has engaged with the United States Marine Corps to explore advanced data transfer techniques. During a recent demonstration involving the Joint Staff J6, Parry Labs worked on the Phantom network gateway...

Continue Reading
Discover Autonomix Medical’s Groundbreaking Presentation at EuroPCR

Updated Category News Views 122

Autonomix Medical's Innovative Contribution to EuroPCR Autonomix Medical, Inc. (NASDAQ: AMIX), a pioneering medical device company, is making waves in the field of interventional cardiology. With a focus on precision nerve-targeted treatments, the company has announced exciting developments that will be showcased in a poster presentation at the renowned EuroPCR. The Event...

Continue Reading